Benitec Biopharma Limited R&D Expenses

R&D Expenses of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including R&D Expenses growth rates and interactive chart. Research and development (R&D) expenses are associated with the research and development of a company's goods or services. A company generally incurs R&D expenses in the process of finding and creating new products or services. It is an operating expense and can be deducted from a company's income taxes.


Highlights and Quick Summary

  • R&D Expenses for the quarter ending December 31, 2022 was $3.76 Million (a 41.39% increase compared to previous quarter)
  • Year-over-year quarterly R&D Expenses increased by 73.24%
  • Annual R&D Expenses for 2022 was $11.3 Million (a 60.57% increase from previous year)
  • Annual R&D Expenses for 2021 was $7.02 Million (a 0.0% decrease from previous year)
  • Annual R&D Expenses for 2021 was $7.02 Million (a 133.92% increase from previous year)
  • Twelve month R&D Expenses ending December 31, 2022 was $11.8 Million (a 5.51% increase compared to previous quarter)
  • Twelve month trailing R&D Expenses increased by 12.96% year-over-year
Trailing R&D Expenses for the last four month:
31 Dec '22 30 Sep '22 30 Jun '22 31 Mar '22
$11.8 Million $11.2 Million $11.3 Million $10.4 Million
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical R&D Expenses of Benitec Biopharma Limited

Most recent R&D Expensesof BNTC including historical data for past 10 years.

Interactive Chart of R&D Expenses of Benitec Biopharma Limited

Benitec Biopharma Limited R&D Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $3.76 $2.66 $3.18 $2.17 $11.27
2021 $3.15 $2.78 $2.32 $2.76 $7.02
2020 $1.17 $0.77 $1.17 $0.81 $3.0
2019 $0.6 $0.42 $4.57
2018 $5.34
2017 $1.11 $5.22
2016 $1.91 $9.68
2015 $5.21
2014 $3.45
2013 $1.32

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology